Brief: Circio Announces Outcome Of EU Patent Proceeding

Circio Holding ASA

24/11/2023 12:03

Nov 24 (Reuters) - Circio Holding ASA  CRNA.OL :
    * CIRCIO ANNOUNCES OUTCOME OF TG01/GEMCITABINE COMBINATION
EU
PATENT PROCEEDING
    * EPO BOARD OF APPEAL MOVED TO REVOKE TG01/GEMCITABINE
COMBINATION
METHOD OF USE PATENT IN PANCREATIC CANCER
    * EPO BOARD OF APPEAL RULED THAT PATENT SHOULD BE REVOKED
DUE TO A
LACK OF SUFFICIENT INVENTIVE STEP BASED ON PRIOR PUBLICATIONS
    * RULING HAS NO IMPACT ON ONGOING CLINICAL STUDIES WHERE
TG01 IS
BEING TESTED WITH NOVEL IMMUNOTHERAPIES

Source text for Eikon:  ID:nObi9yzZKa 
Further company coverage:  CRNA.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))